TRIP13 Induces Nedaplatin Resistance in Esophageal Squamous Cell Carcinoma by Enhancing Repair of DNA Damage and Inhibiting Apoptosis

Thyroid hormone receptor interactor 13 (TRIP13) plays a crucial role in poor prognosis and chemotherapy resistance of cancer patients. This present study is aimed at investigating the role of high expression of TRIP13 inducing nedaplatin (NDP) resistance in esophageal squamous cell carcinoma (ESCC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lin-Ting, Ke, Li-Xin, Wu, Xin-Yi, Tian, Hui-Ting, Deng, Hua-Zhen, Xu, Li-Yan, Li, En-Min, Long, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115607/
https://www.ncbi.nlm.nih.gov/pubmed/35601150
http://dx.doi.org/10.1155/2022/7295458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115607/
https://www.ncbi.nlm.nih.gov/pubmed/35601150
http://dx.doi.org/10.1155/2022/7295458

Ejemplares similares